

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.54637225 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.26425114 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.15785083 |
| 4 | locomotory exploration behavior (GO:0035641) | 6.06830641 |
| 5 | vocalization behavior (GO:0071625) | 5.82632709 |
| 6 | glutamate secretion (GO:0014047) | 5.68416569 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.63743832 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.56717404 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.54849251 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.40965841 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.24456555 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.18662270 |
| 13 | protein localization to synapse (GO:0035418) | 5.08673023 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.86959160 |
| 15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.85789762 |
| 16 | dopamine transport (GO:0015872) | 4.83369064 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.76976061 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.74789956 |
| 19 | exploration behavior (GO:0035640) | 4.69577683 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.63197162 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.61842322 |
| 22 | dendritic spine morphogenesis (GO:0060997) | 4.54450234 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.51043604 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.42357508 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.42245367 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.41707302 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 4.40914687 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 4.35183650 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 4.29821159 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 4.21881236 |
| 31 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.16804924 |
| 32 | long-term memory (GO:0007616) | 4.12795908 |
| 33 | positive regulation of membrane potential (GO:0045838) | 4.12427821 |
| 34 | serotonin metabolic process (GO:0042428) | 4.11819625 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.07598906 |
| 36 | proline transport (GO:0015824) | 4.03824309 |
| 37 | gamma-aminobutyric acid transport (GO:0015812) | 4.00726091 |
| 38 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.92853871 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.87754793 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86074564 |
| 41 | catecholamine transport (GO:0051937) | 3.82743485 |
| 42 | dopamine biosynthetic process (GO:0042416) | 3.82230042 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.80926956 |
| 44 | behavioral response to nicotine (GO:0035095) | 3.78818852 |
| 45 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.73757922 |
| 46 | startle response (GO:0001964) | 3.68912502 |
| 47 | neuron recognition (GO:0008038) | 3.66665682 |
| 48 | postsynaptic membrane organization (GO:0001941) | 3.64466174 |
| 49 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.62388335 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.61266470 |
| 51 | primary amino compound metabolic process (GO:1901160) | 3.60946860 |
| 52 | neurotransmitter transport (GO:0006836) | 3.59728096 |
| 53 | auditory behavior (GO:0031223) | 3.59713877 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.59702485 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58033427 |
| 56 | long-term synaptic potentiation (GO:0060291) | 3.56854333 |
| 57 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.54940469 |
| 58 | neuromuscular synaptic transmission (GO:0007274) | 3.53295550 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.52807347 |
| 60 | positive regulation of neurotransmitter transport (GO:0051590) | 3.51626361 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.49955342 |
| 62 | activation of protein kinase A activity (GO:0034199) | 3.49041190 |
| 63 | alanine transport (GO:0032328) | 3.48340829 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.46834187 |
| 65 | presynaptic membrane assembly (GO:0097105) | 3.46013803 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.45947492 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.44920250 |
| 68 | regulation of dendritic spine development (GO:0060998) | 3.42887546 |
| 69 | response to auditory stimulus (GO:0010996) | 3.42317940 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41399847 |
| 71 | synaptic vesicle endocytosis (GO:0048488) | 3.40709566 |
| 72 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.39206569 |
| 73 | axonal fasciculation (GO:0007413) | 3.39048516 |
| 74 | response to amphetamine (GO:0001975) | 3.38386419 |
| 75 | L-amino acid import (GO:0043092) | 3.35841887 |
| 76 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.33157557 |
| 77 | regulation of neurotransmitter levels (GO:0001505) | 3.31904376 |
| 78 | regulation of neurotransmitter transport (GO:0051588) | 3.31322940 |
| 79 | dendritic spine organization (GO:0097061) | 3.31035291 |
| 80 | phosphorelay signal transduction system (GO:0000160) | 3.30095663 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.29040681 |
| 82 | dendrite morphogenesis (GO:0048813) | 3.27661872 |
| 83 | membrane depolarization (GO:0051899) | 3.25755581 |
| 84 | prepulse inhibition (GO:0060134) | 3.21147626 |
| 85 | positive regulation of dendritic spine development (GO:0060999) | 3.20130655 |
| 86 | learning (GO:0007612) | 3.18954179 |
| 87 | glycine transport (GO:0015816) | 3.18208775 |
| 88 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17727036 |
| 89 | sodium ion export (GO:0071436) | 3.16992583 |
| 90 | presynaptic membrane organization (GO:0097090) | 3.16406544 |
| 91 | response to histamine (GO:0034776) | 3.16245858 |
| 92 | membrane hyperpolarization (GO:0060081) | 3.16108846 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15760916 |
| 94 | neuronal action potential (GO:0019228) | 3.14693797 |
| 95 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.13577361 |
| 96 | positive regulation of synaptic transmission (GO:0050806) | 3.13185927 |
| 97 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.12785943 |
| 98 | righting reflex (GO:0060013) | 3.12178746 |
| 99 | regulation of dopamine secretion (GO:0014059) | 3.11415704 |
| 100 | synapse assembly (GO:0007416) | 3.08780253 |
| 101 | neuronal ion channel clustering (GO:0045161) | 3.07930293 |
| 102 | membrane depolarization during action potential (GO:0086010) | 3.07207054 |
| 103 | regulation of synaptic transmission (GO:0050804) | 3.07044034 |
| 104 | behavioral fear response (GO:0001662) | 3.06829900 |
| 105 | behavioral defense response (GO:0002209) | 3.06829900 |
| 106 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.03264097 |
| 107 | cAMP catabolic process (GO:0006198) | 3.01868439 |
| 108 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.01754300 |
| 109 | social behavior (GO:0035176) | 3.01512886 |
| 110 | intraspecies interaction between organisms (GO:0051703) | 3.01512886 |
| 111 | innervation (GO:0060384) | 3.01316976 |
| 112 | synaptic transmission (GO:0007268) | 3.01232978 |
| 113 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00609159 |
| 114 | behavioral response to cocaine (GO:0048148) | 2.99467338 |
| 115 | cellular potassium ion transport (GO:0071804) | 2.98787846 |
| 116 | potassium ion transmembrane transport (GO:0071805) | 2.98787846 |
| 117 | fear response (GO:0042596) | 2.98594887 |
| 118 | vesicle transport along microtubule (GO:0047496) | 2.97275455 |
| 119 | regulation of ARF protein signal transduction (GO:0032012) | 2.96478004 |
| 120 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96391467 |
| 121 | mechanosensory behavior (GO:0007638) | 2.96166290 |
| 122 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94394845 |
| 123 | regulation of synapse maturation (GO:0090128) | 2.93087276 |
| 124 | cyclic nucleotide catabolic process (GO:0009214) | 2.88741225 |
| 125 | calcium ion-dependent exocytosis (GO:0017156) | 2.86850876 |
| 126 | regulation of dopamine metabolic process (GO:0042053) | 2.86776830 |
| 127 | regulation of catecholamine metabolic process (GO:0042069) | 2.86776830 |
| 128 | cerebellar granule cell differentiation (GO:0021707) | 2.86634647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.07091444 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.70295219 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.14458072 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14415775 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99828108 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72982329 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72982329 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69810346 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64086570 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63742962 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.63378626 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63242755 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.57792699 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52254483 |
| 15 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49764349 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49525263 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49301631 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43956258 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27540516 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.26070495 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22065523 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18581425 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13460919 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04435651 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94697744 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.94204202 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93465032 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92447639 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88236509 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83843644 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82587302 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79653480 |
| 33 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73376805 |
| 34 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72202065 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67411734 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62362708 |
| 37 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59260739 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52469491 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52087925 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48506262 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42773563 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.35617816 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34789995 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34371914 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31811063 |
| 46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30892218 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28350517 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27194671 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25597804 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25472040 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23711893 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22926809 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22884283 |
| 54 | AR_19668381_ChIP-Seq_PC3_Human | 1.20370956 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19643906 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18452668 |
| 57 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17250816 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15869078 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15746579 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15371799 |
| 61 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14847861 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14844741 |
| 63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14751853 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13202346 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13085711 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12964119 |
| 67 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12102004 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11556484 |
| 69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11484998 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11483426 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10272705 |
| 72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10101673 |
| 73 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09810959 |
| 74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09202901 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08521209 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06579878 |
| 77 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06519256 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05902443 |
| 79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05823204 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03773406 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03484931 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03047656 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03031828 |
| 84 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02773188 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02756810 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02687781 |
| 87 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02687781 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02630363 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01160526 |
| 90 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99743477 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99592653 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99269579 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98894732 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98873726 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98279477 |
| 96 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97800088 |
| 97 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96851412 |
| 98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96521447 |
| 99 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96036383 |
| 100 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95117370 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94644587 |
| 102 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94364496 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94311693 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93713995 |
| 105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93460589 |
| 106 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92968980 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92602569 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92602569 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92526715 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92482486 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91818434 |
| 112 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.91400106 |
| 113 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90752063 |
| 114 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90451761 |
| 115 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89261660 |
| 116 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88019070 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87025018 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86879599 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.85777348 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85655903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.14476068 |
| 2 | MP0003880_abnormal_central_pattern | 5.10361723 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.32521766 |
| 4 | MP0004270_analgesia | 4.00778946 |
| 5 | MP0009745_abnormal_behavioral_response | 3.58471228 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.49260295 |
| 7 | MP0002064_seizures | 3.23975974 |
| 8 | MP0002822_catalepsy | 3.15037738 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.08514381 |
| 10 | MP0009046_muscle_twitch | 3.04583238 |
| 11 | MP0005423_abnormal_somatic_nervous | 3.01920245 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.91524117 |
| 13 | MP0001486_abnormal_startle_reflex | 2.79793844 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.67604234 |
| 15 | MP0002272_abnormal_nervous_system | 2.57968229 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.31353438 |
| 17 | MP0002736_abnormal_nociception_after | 2.23545995 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.20203602 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.10199303 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.09357773 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.93615149 |
| 22 | MP0001970_abnormal_pain_threshold | 1.92624073 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.88639701 |
| 24 | MP0003879_abnormal_hair_cell | 1.88158833 |
| 25 | MP0008569_lethality_at_weaning | 1.84266910 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.79771168 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.79193992 |
| 28 | MP0004924_abnormal_behavior | 1.79113577 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.79113577 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.78742099 |
| 31 | MP0000778_abnormal_nervous_system | 1.78431297 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.75723193 |
| 33 | MP0003329_amyloid_beta_deposits | 1.72184003 |
| 34 | MP0004858_abnormal_nervous_system | 1.67180367 |
| 35 | MP0002184_abnormal_innervation | 1.66277388 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.63953186 |
| 37 | MP0000955_abnormal_spinal_cord | 1.48453948 |
| 38 | MP0003633_abnormal_nervous_system | 1.42569668 |
| 39 | MP0001984_abnormal_olfaction | 1.41149925 |
| 40 | MP0004885_abnormal_endolymph | 1.40982834 |
| 41 | MP0002066_abnormal_motor_capabilities/c | 1.40025856 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.39024869 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.38499127 |
| 44 | MP0000569_abnormal_digit_pigmentation | 1.36316133 |
| 45 | MP0001529_abnormal_vocalization | 1.35845504 |
| 46 | MP0003787_abnormal_imprinting | 1.34779786 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.33472900 |
| 48 | MP0001905_abnormal_dopamine_level | 1.30892761 |
| 49 | MP0001188_hyperpigmentation | 1.26357333 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.23299238 |
| 51 | MP0003631_nervous_system_phenotype | 1.17355993 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.11857559 |
| 53 | MP0008872_abnormal_physiological_respon | 1.07484248 |
| 54 | MP0002152_abnormal_brain_morphology | 1.07394484 |
| 55 | MP0004142_abnormal_muscle_tone | 1.05088423 |
| 56 | MP0004147_increased_porphyrin_level | 1.04567083 |
| 57 | MP0003195_calcinosis | 1.03340965 |
| 58 | MP0001177_atelectasis | 1.03180773 |
| 59 | MP0003075_altered_response_to | 0.99144102 |
| 60 | MP0003136_yellow_coat_color | 0.98227470 |
| 61 | MP0008874_decreased_physiological_sensi | 0.97110302 |
| 62 | MP0004742_abnormal_vestibular_system | 0.94203765 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.92989340 |
| 64 | MP0005409_darkened_coat_color | 0.92830721 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 0.90635118 |
| 66 | MP0004043_abnormal_pH_regulation | 0.90497181 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.90373161 |
| 68 | MP0003690_abnormal_glial_cell | 0.89733801 |
| 69 | MP0002229_neurodegeneration | 0.89578585 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.88559682 |
| 71 | MP0010386_abnormal_urinary_bladder | 0.88213621 |
| 72 | MP0005253_abnormal_eye_physiology | 0.86274415 |
| 73 | MP0005535_abnormal_body_temperature | 0.85232679 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.85055218 |
| 75 | MP0003123_paternal_imprinting | 0.84263205 |
| 76 | MP0004133_heterotaxia | 0.84130200 |
| 77 | MP0000920_abnormal_myelination | 0.83017644 |
| 78 | MP0003121_genomic_imprinting | 0.81678951 |
| 79 | MP0000751_myopathy | 0.80315436 |
| 80 | MP0003122_maternal_imprinting | 0.79398321 |
| 81 | MP0003283_abnormal_digestive_organ | 0.79386657 |
| 82 | MP0004085_abnormal_heartbeat | 0.78834491 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.78000706 |
| 84 | MP0003632_abnormal_nervous_system | 0.74657832 |
| 85 | MP0003634_abnormal_glial_cell | 0.74297711 |
| 86 | MP0002102_abnormal_ear_morphology | 0.74224428 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.72323284 |
| 88 | MP0000604_amyloidosis | 0.72260490 |
| 89 | MP0002090_abnormal_vision | 0.72242731 |
| 90 | MP0005499_abnormal_olfactory_system | 0.71700561 |
| 91 | MP0005394_taste/olfaction_phenotype | 0.71700561 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.71480509 |
| 93 | MP0001664_abnormal_digestion | 0.70692920 |
| 94 | MP0000427_abnormal_hair_cycle | 0.69590640 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.68643009 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68244875 |
| 97 | MP0004510_myositis | 0.67995135 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.67991440 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.65483161 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.65179542 |
| 101 | MP0000026_abnormal_inner_ear | 0.63246517 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.59605443 |
| 103 | MP0004484_altered_response_of | 0.59476664 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.56522898 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.55234975 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.53340450 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.53277208 |
| 108 | MP0002653_abnormal_ependyma_morphology | 0.53024718 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.52256677 |
| 110 | MP0010769_abnormal_survival | 0.51815917 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.51481625 |
| 112 | MP0004130_abnormal_muscle_cell | 0.51359337 |
| 113 | MP0002837_dystrophic_cardiac_calcinosis | 0.51133698 |
| 114 | MP0001943_abnormal_respiration | 0.51067639 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.50851050 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.50721523 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.49820559 |
| 118 | MP0003011_delayed_dark_adaptation | 0.49693378 |
| 119 | MP0003861_abnormal_nervous_system | 0.49667711 |
| 120 | MP0002082_postnatal_lethality | 0.49543142 |
| 121 | MP0010770_preweaning_lethality | 0.49543142 |
| 122 | MP0010768_mortality/aging | 0.48571662 |
| 123 | MP0003956_abnormal_body_size | 0.47742625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.42918946 |
| 2 | Myokymia (HP:0002411) | 7.54171086 |
| 3 | Focal seizures (HP:0007359) | 6.05403124 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.37693617 |
| 5 | Visual hallucinations (HP:0002367) | 5.22266289 |
| 6 | Febrile seizures (HP:0002373) | 4.67946878 |
| 7 | Atonic seizures (HP:0010819) | 4.45116496 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.22797819 |
| 9 | Absence seizures (HP:0002121) | 4.18675226 |
| 10 | Broad-based gait (HP:0002136) | 4.14048625 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.10263046 |
| 12 | Poor eye contact (HP:0000817) | 3.97171932 |
| 13 | Dialeptic seizures (HP:0011146) | 3.85617547 |
| 14 | Hyperventilation (HP:0002883) | 3.76028937 |
| 15 | Ankle clonus (HP:0011448) | 3.69837808 |
| 16 | Action tremor (HP:0002345) | 3.66205862 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.62956526 |
| 18 | Papilledema (HP:0001085) | 3.60457842 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.58147648 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.51907870 |
| 21 | Impaired social interactions (HP:0000735) | 3.43858596 |
| 22 | Abnormal social behavior (HP:0012433) | 3.43858596 |
| 23 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.42145666 |
| 24 | Depression (HP:0000716) | 3.21478231 |
| 25 | Mutism (HP:0002300) | 3.14967176 |
| 26 | Dysdiadochokinesis (HP:0002075) | 3.13834884 |
| 27 | Dysmetria (HP:0001310) | 3.13671683 |
| 28 | Postural instability (HP:0002172) | 3.11870556 |
| 29 | Anxiety (HP:0000739) | 3.02498165 |
| 30 | Amblyopia (HP:0000646) | 3.01568814 |
| 31 | Truncal ataxia (HP:0002078) | 3.01200381 |
| 32 | Dyskinesia (HP:0100660) | 2.93465385 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.88859136 |
| 34 | Diminished movement (HP:0002374) | 2.85902680 |
| 35 | Drooling (HP:0002307) | 2.85341588 |
| 36 | Excessive salivation (HP:0003781) | 2.85341588 |
| 37 | Torticollis (HP:0000473) | 2.83704504 |
| 38 | Urinary urgency (HP:0000012) | 2.82653538 |
| 39 | Congenital stationary night blindness (HP:0007642) | 2.82046100 |
| 40 | Impaired smooth pursuit (HP:0007772) | 2.80417286 |
| 41 | Fetal akinesia sequence (HP:0001989) | 2.77362742 |
| 42 | Hypokinesia (HP:0002375) | 2.74849248 |
| 43 | Stereotypic behavior (HP:0000733) | 2.74300173 |
| 44 | Genetic anticipation (HP:0003743) | 2.71662391 |
| 45 | Spastic gait (HP:0002064) | 2.71072587 |
| 46 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.68886065 |
| 47 | Hemiparesis (HP:0001269) | 2.64709294 |
| 48 | Absent speech (HP:0001344) | 2.64000934 |
| 49 | Focal dystonia (HP:0004373) | 2.60885112 |
| 50 | Scanning speech (HP:0002168) | 2.60333414 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.58411138 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.57997306 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.54848266 |
| 54 | Diplopia (HP:0000651) | 2.54848266 |
| 55 | Bradykinesia (HP:0002067) | 2.54312990 |
| 56 | Intention tremor (HP:0002080) | 2.49899258 |
| 57 | Impaired vibratory sensation (HP:0002495) | 2.49694979 |
| 58 | Megalencephaly (HP:0001355) | 2.49527189 |
| 59 | Progressive inability to walk (HP:0002505) | 2.47767625 |
| 60 | Cerebral inclusion bodies (HP:0100314) | 2.46465514 |
| 61 | Gait imbalance (HP:0002141) | 2.45083072 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44527525 |
| 63 | Inability to walk (HP:0002540) | 2.44424437 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.41285792 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.41285792 |
| 66 | Hemiplegia (HP:0002301) | 2.39517115 |
| 67 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.38912501 |
| 68 | Limb dystonia (HP:0002451) | 2.37919906 |
| 69 | Abnormality of the lower motor neuron (HP:0002366) | 2.33609493 |
| 70 | Generalized myoclonic seizures (HP:0002123) | 2.33366381 |
| 71 | Status epilepticus (HP:0002133) | 2.30977264 |
| 72 | Craniofacial dystonia (HP:0012179) | 2.30357142 |
| 73 | Obstructive sleep apnea (HP:0002870) | 2.30274707 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.30231220 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.29444341 |
| 76 | Blue irides (HP:0000635) | 2.26858261 |
| 77 | Type II lissencephaly (HP:0007260) | 2.25135776 |
| 78 | Cerebral hypomyelination (HP:0006808) | 2.24574477 |
| 79 | Lower limb amyotrophy (HP:0007210) | 2.20813959 |
| 80 | Decreased central vision (HP:0007663) | 2.19865803 |
| 81 | Abnormality of the corticospinal tract (HP:0002492) | 2.18788246 |
| 82 | Delusions (HP:0000746) | 2.15856846 |
| 83 | Ventricular fibrillation (HP:0001663) | 2.15564150 |
| 84 | Pancreatic cysts (HP:0001737) | 2.13717609 |
| 85 | Inappropriate behavior (HP:0000719) | 2.13269599 |
| 86 | Insidious onset (HP:0003587) | 2.13108105 |
| 87 | Termporal pattern (HP:0011008) | 2.13108105 |
| 88 | Nephronophthisis (HP:0000090) | 2.11877521 |
| 89 | Pancreatic fibrosis (HP:0100732) | 2.11472556 |
| 90 | Annular pancreas (HP:0001734) | 2.11448303 |
| 91 | Muscular hypotonia of the trunk (HP:0008936) | 2.10074329 |
| 92 | Dysmetric saccades (HP:0000641) | 2.07155660 |
| 93 | Polyphagia (HP:0002591) | 2.04368589 |
| 94 | Medial flaring of the eyebrow (HP:0010747) | 2.03236950 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03144660 |
| 96 | Protruding tongue (HP:0010808) | 2.02648770 |
| 97 | True hermaphroditism (HP:0010459) | 1.97775734 |
| 98 | Incomplete penetrance (HP:0003829) | 1.97272326 |
| 99 | Abnormality of salivation (HP:0100755) | 1.97194642 |
| 100 | Chronic hepatic failure (HP:0100626) | 1.97190332 |
| 101 | Gait ataxia (HP:0002066) | 1.94754408 |
| 102 | Pointed chin (HP:0000307) | 1.94648502 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 1.92312413 |
| 104 | Ankyloglossia (HP:0010296) | 1.91557818 |
| 105 | Retinal dysplasia (HP:0007973) | 1.89936379 |
| 106 | Abnormal EKG (HP:0003115) | 1.89125405 |
| 107 | Clonus (HP:0002169) | 1.88468066 |
| 108 | Agitation (HP:0000713) | 1.85009566 |
| 109 | Clumsiness (HP:0002312) | 1.84884584 |
| 110 | Pheochromocytoma (HP:0002666) | 1.84625239 |
| 111 | Rigidity (HP:0002063) | 1.82263000 |
| 112 | Akinesia (HP:0002304) | 1.82007073 |
| 113 | Hypothermia (HP:0002045) | 1.80305092 |
| 114 | Spastic tetraparesis (HP:0001285) | 1.80270697 |
| 115 | Congenital primary aphakia (HP:0007707) | 1.80178904 |
| 116 | Abnormality of saccadic eye movements (HP:0000570) | 1.79294520 |
| 117 | Insomnia (HP:0100785) | 1.79078432 |
| 118 | Abnormality of the periventricular white matter (HP:0002518) | 1.78460707 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 1.77778359 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.77778359 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 1.77778359 |
| 122 | Bundle branch block (HP:0011710) | 1.76813560 |
| 123 | Resting tremor (HP:0002322) | 1.75828097 |
| 124 | Neuronal loss in central nervous system (HP:0002529) | 1.74799271 |
| 125 | Sleep apnea (HP:0010535) | 1.73716236 |
| 126 | Abnormality of the renal medulla (HP:0100957) | 1.72278039 |
| 127 | Oligodactyly (hands) (HP:0001180) | 1.70819201 |
| 128 | Spastic tetraplegia (HP:0002510) | 1.70475370 |
| 129 | Abnormality of the labia minora (HP:0012880) | 1.69228274 |
| 130 | CNS hypomyelination (HP:0003429) | 1.67660096 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.65642070 |
| 132 | Abnormal drinking behavior (HP:0030082) | 1.65584368 |
| 133 | Polydipsia (HP:0001959) | 1.65584368 |
| 134 | Intellectual disability, severe (HP:0010864) | 1.62469685 |
| 135 | Abolished electroretinogram (ERG) (HP:0000550) | 1.62191275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.21159231 |
| 2 | NTRK3 | 4.24325216 |
| 3 | MAP3K9 | 3.99309772 |
| 4 | MARK1 | 3.23380300 |
| 5 | DAPK2 | 3.14874951 |
| 6 | FRK | 2.80712540 |
| 7 | MAP3K4 | 2.78669130 |
| 8 | MINK1 | 2.48884961 |
| 9 | MAP2K7 | 2.46882107 |
| 10 | PRKD3 | 2.32583658 |
| 11 | PAK6 | 2.26024028 |
| 12 | NTRK2 | 2.20249784 |
| 13 | RIPK4 | 2.05661256 |
| 14 | KSR2 | 1.97718466 |
| 15 | NTRK1 | 1.97246509 |
| 16 | CAMKK1 | 1.93531031 |
| 17 | CASK | 1.93186649 |
| 18 | DAPK1 | 1.85785914 |
| 19 | MAPKAPK5 | 1.85262949 |
| 20 | MAP3K12 | 1.74673667 |
| 21 | MAP2K4 | 1.73980997 |
| 22 | TNIK | 1.70663130 |
| 23 | SIK2 | 1.59956775 |
| 24 | CDK5 | 1.59813992 |
| 25 | KSR1 | 1.57736302 |
| 26 | PRPF4B | 1.49284291 |
| 27 | MAP4K2 | 1.45348990 |
| 28 | TLK1 | 1.44959077 |
| 29 | PLK2 | 1.40878203 |
| 30 | MAPK13 | 1.36600104 |
| 31 | CDK19 | 1.35640548 |
| 32 | MAP3K13 | 1.34365301 |
| 33 | STK39 | 1.34065488 |
| 34 | WNK4 | 1.29347513 |
| 35 | INSRR | 1.25954002 |
| 36 | STK38 | 1.25314750 |
| 37 | GRK5 | 1.24933432 |
| 38 | PRKCG | 1.15781298 |
| 39 | TYRO3 | 1.15573614 |
| 40 | NME1 | 1.14721288 |
| 41 | MAP3K2 | 1.14689433 |
| 42 | FES | 1.14506958 |
| 43 | ARAF | 1.11388878 |
| 44 | TAOK1 | 1.09704083 |
| 45 | CSNK1G3 | 1.06340282 |
| 46 | ADRBK2 | 1.06108982 |
| 47 | CAMK1 | 1.03096103 |
| 48 | CAMKK2 | 1.02573941 |
| 49 | MAP2K6 | 1.02253348 |
| 50 | UHMK1 | 1.00030215 |
| 51 | PNCK | 0.97913653 |
| 52 | BMPR2 | 0.96530800 |
| 53 | CAMK2A | 0.96082336 |
| 54 | BMPR1B | 0.93306420 |
| 55 | STK11 | 0.93213863 |
| 56 | MAP3K11 | 0.91861917 |
| 57 | CSNK1G1 | 0.90203567 |
| 58 | SGK223 | 0.88347082 |
| 59 | SGK494 | 0.88347082 |
| 60 | CDK18 | 0.86875218 |
| 61 | CDK15 | 0.85707449 |
| 62 | LATS2 | 0.84590247 |
| 63 | PHKG1 | 0.83296928 |
| 64 | PHKG2 | 0.83296928 |
| 65 | PRKCH | 0.81054448 |
| 66 | RAF1 | 0.80908233 |
| 67 | CDK14 | 0.79489925 |
| 68 | SGK2 | 0.78195820 |
| 69 | CAMK2B | 0.77828328 |
| 70 | GRK1 | 0.77340193 |
| 71 | OXSR1 | 0.77258545 |
| 72 | SGK1 | 0.77002497 |
| 73 | CDK11A | 0.74507474 |
| 74 | RET | 0.73752381 |
| 75 | ALK | 0.73565948 |
| 76 | CCNB1 | 0.73447341 |
| 77 | MARK2 | 0.71947922 |
| 78 | CSNK1G2 | 0.69922316 |
| 79 | PAK3 | 0.68397565 |
| 80 | SGK3 | 0.67247984 |
| 81 | PTK2B | 0.66934428 |
| 82 | PDK1 | 0.66720044 |
| 83 | PINK1 | 0.63647155 |
| 84 | NEK6 | 0.63602296 |
| 85 | ADRBK1 | 0.63065475 |
| 86 | PDPK1 | 0.60090621 |
| 87 | DYRK1A | 0.59732476 |
| 88 | TRIM28 | 0.57058981 |
| 89 | ACVR1B | 0.56632462 |
| 90 | TNK2 | 0.56036930 |
| 91 | ZAK | 0.54098778 |
| 92 | NUAK1 | 0.53594210 |
| 93 | MAP3K1 | 0.51643242 |
| 94 | DYRK2 | 0.50016040 |
| 95 | LMTK2 | 0.49530673 |
| 96 | PRKCZ | 0.49303871 |
| 97 | PRKCE | 0.48331366 |
| 98 | RPS6KA3 | 0.48142140 |
| 99 | DAPK3 | 0.48036908 |
| 100 | MAP3K7 | 0.47112834 |
| 101 | CAMK4 | 0.46984642 |
| 102 | FYN | 0.46833210 |
| 103 | BCR | 0.46386505 |
| 104 | CSNK1D | 0.44136064 |
| 105 | PRKACA | 0.43912077 |
| 106 | CAMK1G | 0.43298501 |
| 107 | CDC42BPA | 0.42916934 |
| 108 | BUB1 | 0.42604201 |
| 109 | FGR | 0.41729898 |
| 110 | MAPK10 | 0.41011124 |
| 111 | BRSK1 | 0.40247205 |
| 112 | MAP3K6 | 0.40131645 |
| 113 | CAMK1D | 0.39554868 |
| 114 | CAMK2D | 0.39318812 |
| 115 | FGFR2 | 0.37997879 |
| 116 | CSNK1A1 | 0.37501393 |
| 117 | CAMK2G | 0.36092513 |
| 118 | MAPK12 | 0.34852700 |
| 119 | DMPK | 0.34660229 |
| 120 | SIK3 | 0.34183194 |
| 121 | MAP2K1 | 0.34106734 |
| 122 | PKN1 | 0.32624350 |
| 123 | WNK3 | 0.32257905 |
| 124 | TAOK2 | 0.32046318 |
| 125 | RIPK1 | 0.31999331 |
| 126 | CSNK1A1L | 0.31635726 |
| 127 | AKT3 | 0.30855150 |
| 128 | PRKCB | 0.30705942 |
| 129 | PRKCA | 0.26585043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.68950034 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.20556449 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.90556256 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79415764 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.71104235 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.68765492 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68155131 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66644184 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.61795115 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.55618897 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.24914106 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19559544 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.09458141 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07372274 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.01808188 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96023476 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94874867 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76597241 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72395859 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.71039546 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68931963 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.66738978 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65670927 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.64645194 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.62484554 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48325543 |
| 27 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34975898 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.34693197 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32085972 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31806559 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.28673777 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25365600 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.21575497 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20227425 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.17623446 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17569298 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17542913 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15743684 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15004330 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14514532 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13636603 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13598529 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11533183 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09810735 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07128066 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.07025463 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04922021 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03289344 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97341074 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97161870 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95326797 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88860342 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87676355 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85822442 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85776525 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.85535987 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82359119 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82117158 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.81935560 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81261410 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79966022 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75531630 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74816335 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74699504 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74215751 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74136129 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73622379 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73614164 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72350346 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66755502 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65839806 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64118004 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64098877 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63287284 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62647971 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62103882 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59888647 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59532713 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59063863 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56036987 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53957168 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53710340 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.52252898 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51451971 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51095463 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49923498 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47705677 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.47598765 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47590327 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47481930 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47472595 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47213425 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46565170 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45606020 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45396858 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45314675 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44718210 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44383772 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.43881607 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43393444 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43168289 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42605880 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41699751 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41291398 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40595569 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40448779 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.39653971 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39291338 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38455379 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37248059 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37243707 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36801438 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.34846876 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34506609 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33705428 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.32380287 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30733330 |
| 118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30546001 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.30535325 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29703191 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29659733 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29017905 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28009784 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27528626 |
| 125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27052068 |
| 126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26354160 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23222616 |

